Somatization symptomology and its association with stress in patients with irritable bowel syndrome

Somatization symptomology and its association with stress in patients with irritable bowel syndrome

Saved in:

Bibliographic Details
Main Authors:	Saira Akhlaq, Nosheen Kazmi, Syed Murtaza Hassan Kazmi, Muslim Atiq, Sajawal Hussain, Ahmed Bajwa, Abdul Ahad, Muhammad Yaqoob Akhtar, Kalsoom Akhlaq, Mohammad Rizwan
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2025-01-01
Series:	PLoS ONE
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11703010/?tool=EBI
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

On the Pathogenesis of the Irritable Bowel Syndrome: The Irritable Bowel or the Irritable Patient?
by: Stephen M Collins
Published: (1990-01-01)

The impact of locus of control on somatic and psychological profiles of patients with irritable bowel syndrome engaging in aerobic exercise
by: Laura Prospero, et al.
Published: (2025-02-01)

Role of emotional disorders, personality features and disorders of intraceptive sensation in development of somatic symptoms at irritable bowel syndrome
by: Ye. A. Poluektova, et al.
Published: (2013-12-01)

Current Status of the Irritable Bowel Syndrome
by: Stephen M Collins
Published: (1999-01-01)

Motor Function in Irritable Bowel Syndrome
by: Michael Camilleri
Published: (1999-01-01)

Esophageal lesions at irritable bowel syndrome
by: M. G. Mnatsakanyan, et al.
Published: (2015-10-01)

Use of Bismuth in Irritable Bowel Syndrome
by: T. A. Ilchishina
Published: (2021-10-01)

Guidelines on the management of irritable bowel syndrome
by: Anna Pietrzak, et al.
Published: (2018-09-01)

Role of Opioid Ligands in the Irritable Bowel Syndrome
by: Enrico Corazziari
Published: (1999-01-01)

Socioeconomic Impact of Irritable Bowel Syndrome in Canada
by: Michel Boivin
Published: (2001-01-01)

The Role of Mast Cells in Irritable Bowel Syndrome
by: Kang Nyeong Lee, et al.
Published: (2016-01-01)

The Economic Burden of Irritable Bowel Syndrome in Canada
by: Judith D Bentkover, et al.
Published: (1999-01-01)

Irritable Bowel Syndrome in Terms of Changes in the Microbiota
by: Vladimir T. Ivashkin, et al.
Published: (2019-03-01)

Role of nutritional factors at the irritable bowel syndrome
by: Yu. O. Shulpekova, et al.
Published: (2015-10-01)

Irritable bowel syndrome: pathophysiological and clinical issues
by: V. T. Ivashkin, et al.
Published: (2015-03-01)

Dynamics of Somatic and Comorbid Mental Disorders (Distress, Anxiety, Somatisation and Depression) in Patients with Irritable Bowel Syndrome during Therapy with Alimemazine: Results of an Non-Interventional Observational Programme (“Terra”)
by: V. T. Ivashkin, et al.
Published: (2019-01-01)

A European Approach to Irritable Bowel Syndrome Management
by: Michel Delvaux, et al.
Published: (1999-01-01)

Peripheral Mechanisms of Symptom Generation in Irritable Bowel Syndrome
by: Stephen M Collins
Published: (2001-01-01)

A Canadian Perspective on the Management of Irritable Bowel Syndrome
by: Stephen M Collins
Published: (2001-01-01)

Postinfectious Irritable Bowel Syndrome: Polemic and Open Issues
by: A. A. Sheptulin, et al.
Published: (2022-03-01)

Features of nervous system in children with irritable bowel syndrome
by: O. K. Botvin’yev, et al.
Published: (2011-12-01)

Treatment of irritable bowel syndrome: the past, present and future
by: V. T. Ivashkin, et al.
Published: (2015-03-01)

Interrelation of irritable bowel syndrome and bacterial overgrowth: is there any?
by: Yu. A. Kucheryavy, et al.
Published: (2014-08-01)

Long-term results of irritable bowel syndrome treatment
by: A. I. Ulyanin, et al.
Published: (2018-08-01)

Dysphoric spectrum of emotional disorders at irritable bowel syndrome
by: M. A. Morozova, et al.
Published: (2018-08-01)

Acetylcholine in irritable bowel syndrome pathogenesis and the role of cholineblockers
by: Yu. O. Shulpekova
Published: (2011-02-01)

Combination of functional dyspepsia syndrome and irritable bowel syndrome
by: V. T. Ivashkin, et al.
Published: (2011-06-01)

Irritable bowel syndrome: an approach for primary care physicians
by: Zhi En Tan, et al.
Published: (2022-07-01)

Irritable Bowel Syndrome Diagnosis: Should There Be Alertness to Cancer?
by: A. A. Sheptulin, et al.
Published: (2019-05-01)

Symptomological identification of Citrus Psorosis Virus (CPsV) in citrus orchards of Northern Cyprus
by: T. Alas, et al.
Published: (2022-06-01)

Extremal Values of Variable Sum Exdeg Index for Conjugated Bicyclic Graphs
by: Muhammad Rizwan, et al.
Published: (2021-01-01)

El Niño-driven flooding and mental health symptomology among adolescents and young adults in Peru
by: Ilan Cerna-Turoff, et al.
Published: (2025-01-01)

Sexual Abuse in Irritable Bowel Syndrome: To Ask or Not to Ask – That Is the Question
by: Alexandra Ilnyckyj, et al.
Published: (2002-01-01)

A Randomized Trial of Yoga for Adolescents with Irritable Bowel Syndrome
by: Leora Kuttner, et al.
Published: (2006-01-01)

Irritable Bowel Syndrome: New Approaches to Its Pharmacological Management
by: Gervais Tougas
Published: (2001-01-01)

Omentin-1, a Protective Adipokine for Irritable Bowel Syndrome
by: Gao Y, et al.
Published: (2025-02-01)

Benefits from Long-Term Treatment in Irritable Bowel Syndrome
by: Stefano Evangelista
Published: (2012-01-01)

COVID-19 Pandemic and Irritable Bowel Syndrome — is there a Relationship?
by: V. A. Akhmedov
Published: (2022-08-01)

Clinical guidelines for the diagnosis and treatment of patients with irritable bowel syndrome
by: V. T. Ivashkin, et al.
Published: (2014-08-01)

Potential of nutraceutical products for irritable bowel syndrome remission maintenance
by: A. I. Ulyanin, et al.
Published: (2018-08-01)